Two additional targeted biologicals for severe chronic plaque psoriasis are now listed on the Pharmaceutical Benefits Scheme (PBS), offering relief for adults with the often underestimated condition. Chronic plaque psoriasis (often referred to as psoriasis) is thought to affect between...

There has been an increase in incidents of community-associated Staphylococcus aureus bloodstream infections (CA-SABs) in Victoria and Western Australia (WA). Pharmacists have a role to play in infection control and prevention. A study, which surveyed 10,320 hospital-reported S. aureus bacteraemia...

A medication that promises to alleviate symptoms of severe asthma is now listed on the Pharmaceutical Benefits Scheme (PBS) under Section 100, giving patients access to the potentially life-saving treatment.   There are 2.5 million Australians (10% of the population)...

Dementia Australia recently called for shared responsibility between healthcare professionals and aged care organisations in the care of people living with dementia. But where do pharmacists fit into this equation? Dementia Australia CEO Marie McCabe said that a collaborative approach...

Laudanum’s use, and abuse, has set the tone for the use and abuse of opiates from the 17th century until the present day. From pre-history through Sumerian, Greek and Roman cultures, opium has been used for pain management. But...

Psilocybin, a psychoactive compound found in ‘magic mushrooms’, is being trialled in the treatment of terminally ill patients to reduce symptoms of depression and anxiety at Melbourne’s St Vincent’s Hospital. The treatment has proven to be successful in several international...

Australia is in the midst of a record-breaking heatwave – with Western Australia, South Australia, Tasmania, Victoria, the ACT and NSW all reaching maximum temperatures of 8-12°C above average. Parts of South Australia, Victoria and NSW are expected to reach...

Many women in their mid-to-late forties are quick to accept headaches, irritability and memory loss as an unavoidable part of stressful lives. But new research suggests that they might be suffering from perimenopausal depression – an under-researched condition...

Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians. Research has indicated that a new pharmacological approach to treatment could be imminent,1 following the results of a recent study in mice.2 Despite...

More than 1000 people have completed an online assessment in Australian pharmacies to determine their potential risk of developing glaucoma, and there's a call for more pharmacies to get on board. The Glaucoma Risk Calculator allows users to assess their...